Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duration of Protective Effect of Ipratropium on Methacholine Challenge
NCT00605410Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Jan 2008
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Ipratropium Bromide with Placebo (2 arms). Primary endpoint: Methacholine PC20 at 12 hours. Started Jan 2008; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00605410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00605410.